Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-05-11
1994-09-20
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514912, A61K 3710
Patent
active
053489390
ABSTRACT:
A stable and soluble multi-dose ophthalmic solution is disclosed. The solution contains fibronectin, an amino acid, a sugar, and a lower alkyl p-hydroxybenzoate. A method of treatment of ophthalmic wounds employing the ophthalmic solution, a process for preparing fibronectin for ophthalmic use, a method of lyophilizing an aqueous solution of fibronectin free of albumin, a method for inhibiting bacterial growth in an ophthalmic solution while preserving the cellular adhesion and wound healing activities of fibronectin, and a method of treatment of ophthalmic wounds administering a wound-healing accelerator solution are also disclosed.
REFERENCES:
patent: 4740498 (1988-04-01), Hirao et al.
patent: 4837019 (1989-06-01), Georgalas et al.
Stern, M. E. et al., "The Effects of Human Recombinant Epidermal Growth Factor on Epithelial Wound Healing", Healing Processes in the Cornea, pp. 69-77 (C. E. Crosson and H. E. Kaufman, Eds.).
Countois, Y. et al., 181 C. R. Soc. Bio., pp. 491-495 (1987).
Horowitz, B. and Chang, N. Y. "Preparation of Fibronectin for Therapeutic Administration", Fibronectin, pp. 441-455 (Dean S. Mosher, Ed.).
Moses, R. et al., 18 Invest Ophthamal, pp. 103-106.
Nishida, T. et al., 102 Arch Opthamal., p. 455-456.
Gottfried, N. S., "Alkali p-Hydroxybenzoate Esters as Pharmaceutical Preservatives", Am. J. Hosp. Pharm.,19:310-314.
Assouline, M. et al.,"Fibroblast Growth Factor Effects on Cornea Wound Healing in the Rabbit", Healing Processes in the Cornea, pp. 79-97 (Crosson and H. E. Kaufman, Eds.).
Chemical Abstracts, vol. 101, No. 10, p. 368, col. 1, Shiseido Co., Ltd. "Cosmetics containing fibronectins", Abstract No. 78 679b.
Mullen, W. et al., Survey of Ophthalmology, 17:469-483 (1973).
Nelson, J. D. et al., Am. J. of Ophthal. 114:441-447 (1992).
Horowitz Bernard
Kawashima Yoichi
Nishimura Toyohiko
Setton Adrianne J.
Shulman Richard W.
Barnhard Elizabeth M.
Cave Bryan
Fay Zohreh
JCR Pharmaceuticals Co. Ltd.
New York Blood Center Inc.
LandOfFree
Fibronectin-containing ophthalmic solution, method of preserving does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibronectin-containing ophthalmic solution, method of preserving, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibronectin-containing ophthalmic solution, method of preserving will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2429868